A substantial shareholder of Neimeth International Pharmaceuticals Plc, Clinoscope Services Limited, has sold a total of 515.3m ordinary shares of the company, according to a regulatory notification filed with the Nigerian Exchange Limited.
The disclosure recently filed on the Nigerian Exchange Limited shows that the transactions involved the sale of Neimeth’s ordinary shares with ISIN NGNEIMETH001 and were carried out in Lagos between 17 September and 19 December 2025.
Details of the filing indicate that 15.3m shares were sold at N6.10 per share, while an additional 500.0m shares were disposed of at N6.00 per share. The aggregate volume of the shares sold stood at 515.3m units at an average price of N6.05 per share.
Clinoscope Services Limited was identified in the notification as a substantial shareholder of Neimeth International Pharmaceuticals Plc, with the transaction classified as an initial notification in line with market disclosure requirements.
Neimeth International Pharmaceuticals Plc, a listed healthcare company, informed the Exchange of the insider dealing in compliance with post-trade transparency and corporate governance rules aimed at ensuring market integrity and investor awareness.
The company stated that the notification relates solely to the share sale by the shareholder and does not affect its day-to-day operations.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from PUNCH.
Contact: [email protected]
